Skip to main content
Premium Trial:

Request an Annual Quote

ABI Releases TaqMan Assay Data to Public Database

NEW YORK (GenomeWeb News) - Applied Biosystems has released into the public domain the validation data for its TaqMan drug metabolism genotyping assays, the company said today.
 
The data, which was released through the Pharmacogenomics Knowledge Base, is aimed at helping researchers understand how genetic variation among individuals contributes to differences in reactions to drugs.
 
Researchers can use the data on validated genotyping assays available in PharmGKB to “expedite the design and execution of genetic studies correlating genotype to drug efficacy or toxicity,” said Teri Klein, director of the PharmGKB project at Stanford University.
 
Applied Biosystems also said studies show that its TaqMan assays provide higher accuracy than other methodologies in identifying variations in genes that code for drug metabolism enzymes.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.